Wockhardt Limited has informed the Exchange about Credit Rating
WOCKPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.8 pts less than Nifty Smallcap 250 and 1.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
ICRA Limited has upgraded Wockhardt's credit ratings across all its debt instruments from BBB (Positive) to A- (Stable), with short-term ratings also upgraded to A2+. This upgrade reflects the company's improved financial performance, strong market position in formulations in India and Europe, growing presence in emerging markets, adequate liquidity, and a comfortable capital structure. The rating agency also cited scale expansion of value-accretive products and new chemical entities (NCEs) as positive factors.
This is a positive development for shareholders as the upgrade signals improved creditworthiness and financial health, which could lower borrowing costs and boost investor confidence in the stock.